Niowave Inc.

Private

Lansing, MichiganHealthcare & Life Scienceshttps://niowaveinc.com/

Last Round

Strategic

Feb 11, 2026

Total Funding Raised

$15.75M

Company Overview

Niowave Inc. is a healthtech and manufacturing company that develops and operates superconducting electron linear accelerators for the production of medical radioisotopes used in cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Precision Medicine, Defense Tech, Biotech Equipment

Business Model

B2B

Customer Profile

Government Contracts, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical radioisotopessuperconducting linear acceleratorActinium-225isotope manufacturinglinacradioligand therapyradiopharmaceuticalsreactor-free isotopesdomestic isotope supplypharma supply chainMolybdenum-99radiochemistry servicesisotope supply agreementsaccelerator technologyaccelerator components

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Niowave Inc. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Niowave Inc. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	Feb 11, 2026
Grant	Oct 14, 2025
Grant	Apr 11, 2023
VC Round	Jan 21, 2022
Grant	Dec 3, 2021
Grant	Nov 20, 2013

View all Funding Rounds

Key People

Founding team and executive leadership

Terry Grimm

Founder & Chief Science Officer

Founding Team

Adam Havey

Chief Operating Officer

Executive Team

Jerry Hollister

Director Of Government Contracts Chief Operating Officer, Board Of Directors

Executive Team

Niowave Inc. Investors

Notable investors and investment history

Investor	Rounds
U.S. Department of Energy's National Nuclear Security Administration	Grant
Michigan Strategic Fund	Grant
Michigan Economic Development Corporation	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 11, 2026
Novartis led the strategic round.
Oct 14, 2025
$751K grant from Michigan Strategic Fund

View all signals

Niowave Inc. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Niowave Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Niowave Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersLansing, Michigan

Employee Range173

Year Founded2005

Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.